The store will not work correctly when cookies are disabled.
2-(4-fluorophenyl)-4H-thiochromen-4-one 1,1-dioxide
ID: ALA5199525
PubChem CID: 168291466
Max Phase: Preclinical
Molecular Formula: C15H9FO3S
Molecular Weight: 288.30
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C=C(c2ccc(F)cc2)S(=O)(=O)c2ccccc21
Standard InChI: InChI=1S/C15H9FO3S/c16-11-7-5-10(6-8-11)15-9-13(17)12-3-1-2-4-14(12)20(15,18)19/h1-9H
Standard InChI Key: VBTQIGUSJWCWRT-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-0.7147 1.8562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 1.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 0.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 -0.6188 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.4291 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4291 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1409 1.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8554 0.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8554 -0.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1391 -0.6180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1280 -1.3346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3030 -1.3346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7143 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 -0.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1409 -0.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1409 -1.4437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4307 -1.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7143 -1.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8554 -1.8562 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 1 0
7 2 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 12 2 0
5 13 2 0
14 4 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
14 19 1 0
19 18 2 0
17 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.30 | Molecular Weight (Monoisotopic): 288.0256 | AlogP: 2.84 | #Rotatable Bonds: 1 |
Polar Surface Area: 51.21 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.56 | CX LogD: 2.56 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.81 | Np Likeness Score: -0.66 |
References
1. Gupta O, Pradhan T, Bhatia R, Monga V.. (2021) Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships., 223 [PMID:34171661] [10.1016/j.ejmech.2021.113606] |